Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Sep 23, 2022 10:06am
184 Views
Post# 34981552

RE:RE:RE:RE:RE:Financing

RE:RE:RE:RE:RE:Financing
enriquesuave wrote:

A 5% dilution took us down temporarily almost 30% from 0.35.

 

StevenBirch wrote: Yes this has been hanging over the stock for weeks and now it's out of the way. The stock will always trade down to where the PP was done, in this case before the announcement rather than after so it should be a gradual climb from here as we get closer to the next update.

 

 

Yajne wrote: P.S. nice to 'non-brokered' as well...specifically the Mackie was nowhere near this thing. Non-brokered financings are usually a good omen IMO, the fact that they were able to round up the funds fairly easily incl $600K from insiders which is also a good signal.

Yajne wrote: IMO, we go up from here in anticipation of BTD and AA. The 'writing on the wall' was obvious after Q2 released for anybody with a basic knowledge of financial statements. They had cash to end of Q3 or possibly a month more based on monthly burn rate. This small tuck-in financing is IMO exactly what the doctor ordered at this point and puts the $$ question behind us until will into 2023 when SP should be a completely different level when BTD and AA achieved...and talk of other indications begins to enter the discussion again. So KUDOS to TLT mgmt for this small financing.

enriquesuave wrote: Good. At least company has about $3.6 Million in cash now until at least a year and now will prepare for GBM and NSCLC as well. They can't wait till last minute.  Next catalyst will see warrants excercised I hope and more cash.  

 

 

 




Was it really a 5% dilution? By my count we have had quite a few 'chunks' of warrants expire in the last cpl of years. And another chunk likely to expire in 10 days. So these 20Mil shares/warrants gets the float back to ~ 300Mil shares/warrants. My calculations haven't changed.

<< Previous
Bullboard Posts
Next >>